These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21904160)

  • 21. [Oral contraceptives and ophthalmic arterial pressure].
    Boissin JP
    Bull Soc Ophtalmol Fr; 1971; 71(9):872-4. PubMed ID: 5151031
    [No Abstract]   [Full Text] [Related]  

  • 22. [Oral contraceptives and oral candidiasis].
    Krekeler G; Ochs G; Haderthauer W
    Fortschr Med; 1981 Feb; 99(7):230-2. PubMed ID: 7216106
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral contraceptive steroids and atherosclerosis: lipogenesis in human arterial smooth muscle cells and dermal fibroblasts in presence of lipoprotein-deficient serum from oral contraceptive users.
    Subbaiah PV; Bagdade JD
    Artery; 1980; 6(6):437-57. PubMed ID: 7436743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malignant arterial hypertension and oral contraceptives. Apropos of 4 cases].
    Saint-Hillier Y; Baumont N; Colomb H; Pageaut G; Perol C
    J Urol Nephrol (Paris); 1977 Sep; 83(9):673-9. PubMed ID: 926229
    [No Abstract]   [Full Text] [Related]  

  • 25. Re "Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors" by A. Luckish et al.
    Ye Y; Hu SJ
    Bone; 2009 Sep; 45(3):609-10; author reply 611. PubMed ID: 19465167
    [No Abstract]   [Full Text] [Related]  

  • 26. [Arterial hypertension and oral contraceptives (author's transl)].
    Lekieffre J
    Ann Cardiol Angeiol (Paris); 1979; 28(1):35-9. PubMed ID: 434757
    [No Abstract]   [Full Text] [Related]  

  • 27. [The importance of risk factors in cerebrovascular processes while taking oral contraceptives (author's transl)].
    Holtmann W; Berger G
    MMW Munch Med Wochenschr; 1977 Dec; 119(48):1557-60. PubMed ID: 414098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does serelaxin treatment alter passive mechanical wall properties in small resistance arteries?
    Jelinic M; Kahlberg N; Parry LJ; Tare M
    Microcirculation; 2016 Nov; 23(8):631-636. PubMed ID: 27653183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptives and riboflavin nutriture.
    Guggenheim K; Segal S
    Int J Vitam Nutr Res; 1977; 47(3):234-5. PubMed ID: 914458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptives: mechanisms in thromboembolism.
    Lancet; 1980 May; 1(8178):1118-9. PubMed ID: 6103446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ovulation inhibitors from a neurological viewpoint].
    Gschwend J
    Schweiz Med Wochenschr; 1976 May; 106(19):644-7. PubMed ID: 996486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Causal relationship between the use of oral contraceptives and neurological complications? Presentation of a case of extensive cerebral vein thrombosis].
    Filippa G; Regli F; Noseda G
    Munch Med Wochenschr; 1967 Mar; 109(13):691-8. PubMed ID: 5631730
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oral contraceptives, a new risk factor in the production of cerebral arterial occlusive diseases in women].
    Berheci AL
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(2):89-92. PubMed ID: 1081267
    [No Abstract]   [Full Text] [Related]  

  • 34. [Internal medicine reflections on hormonal contraception].
    Halhuber C
    Ther Ggw; 1975 Sep; 114(9):1405-25. PubMed ID: 1188696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eruptions due to oral contraceptives.
    Coskey RJ
    Arch Dermatol; 1977 Mar; 113(3):333-4. PubMed ID: 843100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Harmful effects of common drugs on the visual apparatus. Hormones. VI. Oral contraceptives].
    van Oye R
    Bull Soc Belge Ophtalmol; 1972; 160(1):298-317. PubMed ID: 5047220
    [No Abstract]   [Full Text] [Related]  

  • 37. [Budd-Chiari syndrome following intake of oral contraceptives (author's transl)].
    Gstöttner H; Rothe K; Leitsmann H; Langpeter D
    Zentralbl Gynakol; 1980; 102(3):146-50. PubMed ID: 7211027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptives use and liver tumours: a review.
    Kenya PR
    East Afr Med J; 1990 Mar; 67(3):146-53. PubMed ID: 2191857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Third-generation oral contraceptives and venous thrombosis.
    Vandenbroucke JP; Helmerhorst FM; Bloemenkamp KW; Rosendaal FR
    Lancet; 1997 Mar; 349(9053):731; author reply 732-3. PubMed ID: 9078225
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hormonal contraceptives and myocardial infarct].
    Sefidpar M; Bieler M; Reutter FW
    Schweiz Med Wochenschr; 1975 Jun; 105(26):836-9. PubMed ID: 1215881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.